Table 2.
Region | Country | GRISP categories |
|||||
---|---|---|---|---|---|---|---|
SIAs used to identify children unvaccinated or under-vaccinated with antigens other than measles and rubella | Used to strengthen RI in other ways, e.g. social mobilization, health care worker refresher training, additional resources for RI, etc. | MR surveillance used to strengthen other VPD surveillance, identify high-risk communities, etc. | MR outbreak investigation used to strengthen RI, e.g. prioritize low coverage communities for antigens other than measles and rubella | Adoption of MR elimination goal used to close immunity gaps with antigens other than measles and rubella, e.g. through 2YL, MCV2 or RCV introduction, school entry requirements, adult vaccination, etc. | Expansion of HCWs ‘terms of reference, specifically to include RI strengthening activities | ||
AFR | Eritrea | X | |||||
Ethiopia | X | X | |||||
Kenya | X | ||||||
Liberia | X | ||||||
Malawi | X | ||||||
Nigeria | X | ||||||
Namibia | X | ||||||
Rwanda | X | ||||||
Tanzania | X | ||||||
AMR | Honduras | X | X | ||||
Mexico | X | X | X | ||||
EMR | Pakistan | X | X | ||||
EUR | Austria | X | |||||
France | X | ||||||
Germany | X | ||||||
SEAR | India | X | |||||
Indonesia | X | ||||||
Timor Leste | X | ||||||
WPR | Cambodia | X | X | ||||
Japan | X | ||||||
Lao PDR | X | X | |||||
Malaysia | X | X | X | ||||
Rep Korea | X | ||||||
Total | 23 | 6 | 15 | 5 | 2 | 2 | 1 |